Q3 2016 Holdings
Filed 2016-11-02 | 11 holdings | $131.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Juno Therapeutics | Common Stock | 48205A109 | $36.9K | 1,229,512 | 28.2% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $33.8K | 2,600,410 | 25.8% |
| Egalet | Common Stock | 28226B104 | $22.0K | 2,889,926 | 16.8% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $17.0K | 822,175 | 13.0% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $8.1K | 1,145,890 | 6.2% |
| Essa Pharma | Common Stock | 29668H104 | $4.7K | 1,696,969 | 3.6% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $3.4K | 1,848,984 | 2.6% |
| Proteon Therapeutics | Common Stock | 74371L109 | $2.3K | 250,000 | 1.8% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $1.3K | 223,457 | 1.0% |
| Editas Medicine(EDIT) | Common Stock | 28106W103 | $892 | 66,162 | 0.7% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $585 | 301,477 | 0.4% |